These changes provide further evidence that DNMT1 is involved in the progression of BC through an epigenetic inactivation of BRCA1 and that DNMT1 inhibition by TQ could be a key event modulating the inhibition of BC proliferation and metastasis. The gene discussed is DNMT1; the disease is breast cancer.